NUBEQA $0 Co-Pay Program TERMS & CONDITIONS
- Patient must meet the eligibility requirements of the NUBEQA $0 Co-Pay Program; for example, only commercially insured patients are eligible
- Patient must inform the NUBEQA $0 Co-Pay Program of change in insurance status
- It is required that the patient understand, accept, and meet the terms of all the NUBEQA $0 Co-pay Program requirements
- Use of the NUBEQA $0 Co-pay Program must be consistent with and not prohibited by the requirements of the patient’s health insurance
- The NUBEQA $0 Co-pay Program benefit has a max amount of $25,000 per year, per patient
- The NUBEQA $0 Co-pay Program is for commercially insured patients using NUBEQA for an approved FDA indication
- The NUBEQA $0 Co-pay Program does not cover costs for charges associated with patient visits
- Offer valid only for patients treated in the USA, including Puerto Rico, Guam and US Territories
- Bayer reserves the right to determine eligibility, monitor participation, equitably distribute product and modify or discontinue the NUBEQA $0 Co-Pay Program at any time with or without notice
- Patient agrees to provide necessary health information to the administrators of the NUBEQA $0 Co-Pay Program
- For questions about the NUBEQA $0 Co-Pay Program, please call us at 1-647-245-5642.